Adma Biologics ADMA
NASDAQ ADMA
$9.96 -0.16 (-1.58%)
At close: Sep 29, 2026 · 4:00 PM EDT

Adma Biologics (ADMA) Receivables (2012 - 2026)

Updated

Adma Biologics' Receivables was $138.23 million in Q2 2026, up 26.0% from $109.73 million a year earlier and up 1.7% from the prior quarter.

Analysis

Adma Biologics (ADMA) Receivables (2012 - 2026) Analysis & Trends

At the end of FY2025, Receivables at Adma Biologics came in at $158.43 million, up 216.9% from FY2024.

  • Receivables has now increased for three consecutive years, with a five-year compound annual growth rate of 64.3% (FY2020 to FY2025).
  • In earlier years, Receivables was $50 million in FY2024 (+82.3%), $27.42 million in FY2023 (+76.9%), $15.51 million in FY2022 (-45.7%) and $28.58 million in FY2021 (+115.9%).
  • Quarterly Receivables has moved between $15.51 million (Q4 2022) and $158.43 million (Q4 2025) over five years.
  • Compared with a year earlier, Receivables has increased for eight straight quarters, with growth averaging 120.2% over the last eight quarters.
  • The best year-over-year quarter for Receivables over five years was Q2 2025 (growth of 264.4%); the worst was Q4 2022 (a decline of 45.7%).
  • Per Business Quant data, ADMA's Receivables in the three quarters before Q2 2026 was $135.86 million (Q1 2026), $158.43 million (Q4 2025) and $137.67 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 19.05 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 13.82 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.56 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 9.64 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.68 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.23 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 5.06 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 12.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.13 Bn
10 Adma Biologics 2.28 Bn 1.86 Bn 86.28 Mn 138.23 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 138.23 Mn
Mar 31, 2026 135.86 Mn
Dec 31, 2025 158.43 Mn
Sep 30, 2025 137.67 Mn
Jun 30, 2025 109.73 Mn
Mar 31, 2025 99.41 Mn
Dec 31, 2024 50.00 Mn
Sep 30, 2024 50.14 Mn
Jun 30, 2024 30.11 Mn
Mar 31, 2024 49.62 Mn
Dec 31, 2023 27.42 Mn
Sep 30, 2023 31.32 Mn
Jun 30, 2023 36.73 Mn
Mar 31, 2023 26.52 Mn
Dec 31, 2022 15.51 Mn
Sep 30, 2022 20.90 Mn
Jun 30, 2022 18.88 Mn
Mar 31, 2022 25.63 Mn
Dec 31, 2021 28.58 Mn
Sep 30, 2021 20.39 Mn
API Access

Adma Biologics Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=ADMA&period=max&api_key=YOUR_API_KEY